Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:669 (18 March), doi:10.1136/bmj.332.7542.669
| The first 150 words of the full text of this article appear below. |
EDITORBarlow argues that prognostic assessment will be important in a flu pandemic.1 Although the predictive tools CURB-65 and CRB-65 have been validated in terms of 30 day mortality,2 their limitations with respect to prediction of mortality have recently been highlighted. Their value as a track and triage tool has not been established.
This is of prime importance as the numbers of presentations expected during a flu pandemic require that an instrument be developed which recognises the physiological derangement and social and comorbid factors which normally influence hospital admission criteria. Ideally, this tool would be applicable across the health economy and amenable to use in primary and secondary care by medical, nursing, and allied health professionals.
Given the magnitude of a pandemic (we calculate that attendances at our emergency department may be in excess of 600% of normal3), it is imperative that any clinical guidance recognises that degradation
Kirsty Challen, research fellow in emergency medicine
kirsty.challen@smtr.nhs.uk South Manchester University Hospitals Trust, Manchester M23 9LT
John Bright, specialist registrar in respiratory medicine, Andrew Bentley, consultant in respiratory medicine and critical care, Darren Walter, clinical director, emergency medicine
South Manchester University Hospitals Trust, Manchester M23 9LT